BIOCONTROL TECHNOLOGY INC
8-K, 1999-09-09
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: AFL CIO HOUSING INVESTMENT TRUST, N-30D, 1999-09-09
Next: MERRILL LYNCH MUNICIPAL BOND FUND INC, 24F-2NT, 1999-09-09





               SECURITIES AND EXCHANGE COMMISSION

                     Washington, D.C.  20549

                            FORM 8-K

                         CURRENT REPORT

             Pursuant to Section 13 or 15(d) of the
                 Securities Exchange Act of 1934

                       ___________________


  Date of Report (Date of earliest event reported) September 9, 1999

                   BIOCONTROL TECHNOLOGY, INC.
     (Exact name of registrant as specified in its charter)


 Pennsylvania                     0-10822                 25-1229323
(State of other jurisdiction  (Commission File Number)  (IRS Employer
 of incorporation)                                       Identification No.)


      300 Indian Springs Road, Indiana, Pennsylvania 15701
    (Address of principal executive offices)    (Zip Code)


Registrant's telephone number, including area code (412) 349-1811



_________________________________________________________________
                 (Former name or former address,
                  if changes since last report.)







Item 1.   Change in Control of Registrant.
          Not applicable.

Item 2.   Acquisition or Disposition of Assets.
          Not applicable.

Item 3.   Bankruptcy or Receivership.
          Not applicable.

Item 4.   Changes in Registrant's Certifying Accountant
          Not applicable.

Item 5.   Other Events.

          In  September 1999, the Company entered into a contract
          with a major health care institution in connection with
          its Diasensor 2000 noninvasive glucose sensor. The health
          care institution, which developed the protocol for the
          clinical  trials, has agreed to conduct the Company's
          clinical trials of the sensor, and to work with the FDA
          to assure compliance with FDA recommendations.

Item 6.   Resignation of Registrant's Directors.
          Not Applicable

Item 7.   Financial Statement, Pro Forma Financial Information
          and Exhibits.

          (a)  Financial Statements and Businesses Acquired - Not Applicable.

          (b)  Pro Forma Financial Information - Not Applicable.

          (c)  Exhibits - None.

                           SIGNATURES

      Pursuant to the requirement of the Securities Exchange  Act
of  1934, the Registrant has duly caused this Report to be signed
on its behalf by the undersigned hereunto duly authorized.

                                   BIOCONTROL TECHNOLOGY, INC.

                                   by  /s/   Fred E. Cooper
                                             Fred E. Cooper, CEO

DATED:  September 9, 1999





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission